• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SMITH & NEPHEW MEDICAL LTD. MELOLIN P/PACK 5X5CM BE CTN 25; DRESSING,WOUND,OCCLUSIVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SMITH & NEPHEW MEDICAL LTD. MELOLIN P/PACK 5X5CM BE CTN 25; DRESSING,WOUND,OCCLUSIVE Back to Search Results
Catalog Number 66030260
Device Problem Moisture or Humidity Problem (2986)
Patient Problem Tissue Damage (2104)
Event Date 11/06/2019
Event Type  Injury  
Event Description
It was reported that there was maceration caused by moisture while using melolin.It is unknown if medical intervention was needed.
 
Manufacturer Narrative
The device, intended for use in treatment, or a control sample, has not been returned for evaluation.Without this we are unable to complete an analysis to establish a relationship between the failure reported.Medical/clinical investigation reported that without product lot, return for evaluation and/or clinically relevant supporting documentation, a thorough medical investigation could not be performed.Patient impact beyond the reported maceration could not be assessed.Should clinical documentation become available in the future, the clinical/medical task may be re-evaluated.No further medical assessment is warranted at this time.A risk management review has taken place in relation to this complaint, the risk file contains multiple causes of decreased absorption or reduced fluid uptake which among other harms can lead to wound maceration.Without further details a full failure mode cannot be identified.A review of the instructions for use found adequate warnings, precautions relating to the product range.Indications - melolin may be used on its own to dress dry sutured wounds, superficial cuts and abrasions, and other lightly exuding lesions.It may also be used as the primary wound contact layer for more heavily exuding wounds, if backed by a second absorbent dressing.Contra-indications - in common with other perforated plastic film dressings, melolin should be used with caution in the treatment of leg ulcers that produce copious quantities of very viscous exudate.Under these circumstances, the exudate may become trapped under the dressing, leading to maceration and inflammation of the surrounding skin.A review of the device history has also not been possible, however all products released are done so according to design specification, there is no indication that the product failed to meet this.Complaint history for the reported failure has been reviewed and revealed this complaint as the only instance in the previous four years.We have been unable to determine a root cause on this occasion.No further actions by smith and nephew are deemed necessary at this stage.However, we will continue to monitor for any adverse trends relating to this product range.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MELOLIN P/PACK 5X5CM BE CTN 25
Type of Device
DRESSING,WOUND,OCCLUSIVE
Manufacturer (Section D)
SMITH & NEPHEW MEDICAL LTD.
101 hessle road
hull
UK 
MDR Report Key9409522
MDR Text Key169022483
Report Number8043484-2019-00880
Device Sequence Number1
Product Code NAD
Combination Product (y/n)N
PMA/PMN Number
K821246
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 05/11/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/04/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number66030260
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Date Manufacturer Received04/17/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-